ACCD Logo

Accolade, Inc. (ACCD) 

NASDAQ
Market Cap
$297.18M
Sector
Healthcare
Industry
Medical—Healthcare Information Services
Rank in Sector
407 of 775
Rank in Industry
16 of 32

Largest Insider Buys in Sector

ACCD Stock Price History Chart

ACCD Stock Performance

About Accolade, Inc.

Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves …

Insider Activity of Accolade, Inc.

Over the last 12 months, insiders at Accolade, Inc. have bought $0 and sold $2.42M worth of Accolade, Inc. stock.

On average, over the past 5 years, insiders at Accolade, Inc. have bought $178,758 and sold $4.23M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 74 shares for transaction amount of $743 was made by Barnes Stephen H. (Chief Financial Officer) on 2022‑08‑02.

List of Insider Buy and Sell Transactions, Accolade, Inc.

2024-11-19SaleChief Executive Officer
380
0.0005%
$3.35$1,271+5.38%
2024-11-19SaleChief Financial Officer
121
0.0001%
$3.35$405+5.38%
2024-11-19SalePresident
154
0.0002%
$3.35$515+5.38%
2024-11-12SaleChief Executive Officer
668
0.0008%
$3.64$2,430-2.43%
2024-11-12SaleChief Financial Officer
223
0.0003%
$3.64$811-2.43%
2024-11-12SalePresident
214
0.0003%
$3.64$779-2.43%
2024-11-04SaleChief Executive Officer
1,545
0.0019%
$3.15$4,865+13.02%
2024-11-04SaleChief Financial Officer
458
0.0006%
$3.15$1,442+13.02%
2024-11-04SalePresident
475
0.0006%
$3.15$1,496+13.02%
2024-11-04SaleChief Accounting Officer
448
0.0005%
$3.15$1,411+13.02%
2024-11-04SaleEVP General Counsel
336
0.0004%
$3.15$1,058+13.02%
2024-10-17SaleChief Executive Officer
385
0.0005%
$3.67$1,413-2.65%
2024-10-17SaleChief Financial Officer
122
0.0002%
$3.67$448-2.65%
2024-10-17SalePresident
157
0.0002%
$3.67$576-2.65%
2024-10-11SaleChief Executive Officer
680
0.0008%
$3.77$2,564-6.07%
2024-10-11SaleChief Financial Officer
228
0.0003%
$3.77$860-6.07%
2024-10-11SalePresident
217
0.0003%
$3.77$818-6.07%
2024-10-02SaleChief Executive Officer
1,540
0.0018%
$3.70$5,704-2.92%
2024-10-02SaleChief Financial Officer
456
0.0005%
$3.70$1,689-2.92%
2024-10-02SalePresident
474
0.0006%
$3.70$1,756-2.92%

Insider Historical Profitability

16.34%
SINGH RAJEEVChief Executive Officer
796109
0.9885%
$3.69165+16.34%
Barnes Stephen H.Chief Financial Officer
205292
0.2549%
$3.69264+16.34%

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Brown Advisory$61.27M7.425.85M-1.96%-$1.22M0.08
BlackRock$59.33M7.185.66M+<0.01%+$2,378.96<0.01
ARK Investment Management LLC$58.82M7.125.61M-17.52%-$12.49M0.2
The Vanguard Group$56.63M6.855.4M+1.45%+$807,421.12<0.01
JPMorgan Chase$55.87M6.765.33M-16.83%-$11.31M0.01
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.